Condition
Severe Primary Immunodeficiency Disorder
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Stem Cell Infusion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
1Total
Phase 1/2 (1)
Trial Status
Terminated1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Stem Cell Infusion1
- Anticd451
- Alemtuzumab1
Active Sponsors
- Center for Cell and Gene Therapy, Baylor College of Medicine1
- Baylor College of Medicine1
Top Investigators
Baylor College of Medicine
Baylor College of Medicine
Related Conditions
- Severe Combined Immunodeficiency Disease1
- Wiskottaldrick Syndrome1
- Undefined T Cell Deficiency Disorder1